| |
| | Lymphoma, non-Hodgkin's, adult: Treatment - Health Professional Information [NCI PDQ] |
 | | Follicular lymphoma comprises 20% of all non-Hodgkin’s lymphomas and as many as 70% of the indolent lymphomas reported in American and European clinical trials.[7,8,11] Most patients with follicular lymphoma are 50 years and older and present with widespread disease at diagnosis. |
 | | Lymphoplasmacytic lymphoma is usually associated with a monoclonal serum paraprotein of immunoglobulin M type (Waldenström’s macroglobulinemia).[20,21,22] Most patients have bone marrow, lymph node, and splenic involvement, and some patients may develop hyperviscosity syndrome. |
 | | Splenic marginal zone lymphoma is an indolent lymphoma that is marked by massive splenomegaly and peripheral blood and bone marrow involvement, usually without adenopathy.[64,65] This type of lymphoma is otherwise known as splenic lymphoma with villous lymphocytes, an uncommon variant of B-cell chronic lymphocytic leukemia. |
| www.peacehealth.org /kbase/nci/ncicdr0000062707.htm (12425 words) |
|